跳至主要内容
临床试验/IRCT138904151179N4
IRCT138904151179N4已完成未知

Effect of raloxifen in post menopausal women with diabetic nephropathy

Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 70 years(—)
性别
Female

入选标准

  • Inclusion Criteria : confirmed menopause (last period of the patient over the past year and FSH levels is more than 25mu/L, Age less than 70 years, confirmed albuminuria due to DM (ACR> 30mg/gr)
  • Exclusion criteria: History of Treatment with estrogen or SERM in the past six months, a personal history of breast or Genicologic cancer, History of thrombotic disorders, GFR less than 30 mL/min, hypertriglyceridemia over than 400 mg/dl, Active liver disease, intolerance to raloxifene or other Allergic reactions

排除标准

  • 未提供

研究者

发起方
Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences

相似试验